Amphenol Corporation vs Gilead Sciences, Inc.
Vergleich der Marktkapitalisierung im Zeitverlauf
Amphenol Corporation
$182.7B
Rang #86
Gilead Sciences, Inc.
$193.5B
Rang #81
Marktkapitalisierung im Zeitverlauf
Wichtige Momente
- Gilead Sciences, Inc. überholte Amphenol Corporation bis 1995
- Amphenol Corporation überholte Gilead Sciences, Inc. bis 2025
- Gilead Sciences, Inc. überholte Amphenol Corporation bis 2026
Vergleich Jahr für Jahr
| Jahr | Amphenol Corporation | Gilead Sciences, Inc. | Spitzenreiter |
|---|---|---|---|
| 2026 | $182.7B | $193.5B | Gilead Sciences, Inc. |
| 2025 | $165.6B | $150.5B | Amphenol Corporation |
| 2024 | $84.4B | $110.0B | Gilead Sciences, Inc. |
| 2023 | $59.8B | $92.6B | Gilead Sciences, Inc. |
| 2022 | $45.4B | $94.6B | Gilead Sciences, Inc. |
| 2021 | $51.6B | $76.4B | Gilead Sciences, Inc. |
| 2020 | $38.2B | $58.7B | Gilead Sciences, Inc. |
| 2019 | $31.3B | $63.0B | Gilead Sciences, Inc. |
| 2018 | $23.2B | $58.5B | Gilead Sciences, Inc. |
| 2017 | $24.9B | $65.0B | Gilead Sciences, Inc. |
| 2016 | $18.9B | $63.2B | Gilead Sciences, Inc. |
| 2015 | $14.6B | $87.4B | Gilead Sciences, Inc. |
| 2014 | $14.9B | $80.8B | Gilead Sciences, Inc. |
| 2013 | $12.2B | $64.4B | Gilead Sciences, Inc. |
| 2012 | $8.8B | $31.5B | Gilead Sciences, Inc. |
| 2011 | $6.1B | $17.6B | Gilead Sciences, Inc. |
| 2010 | $7.1B | $15.5B | Gilead Sciences, Inc. |
| 2009 | $6.2B | $18.6B | Gilead Sciences, Inc. |
| 2008 | $3.2B | $21.9B | Gilead Sciences, Inc. |
| 2007 | $6.2B | $19.7B | Gilead Sciences, Inc. |
| 2006 | $4.2B | $13.9B | Gilead Sciences, Inc. |
| 2005 | $3.0B | $11.3B | Gilead Sciences, Inc. |
| 2004 | $2.4B | $7.5B | Gilead Sciences, Inc. |
| 2003 | $2.1B | $6.2B | Gilead Sciences, Inc. |
| 2002 | $1.3B | $3.6B | Gilead Sciences, Inc. |
| 2001 | $1.6B | $3.5B | Gilead Sciences, Inc. |
| 2000 | $1.3B | $2.2B | Gilead Sciences, Inc. |
| 1999 | $1.1B | $1.5B | Gilead Sciences, Inc. |
| 1998 | $503.2M | $1.1B | Gilead Sciences, Inc. |
| 1997 | $928.2M | $1.0B | Gilead Sciences, Inc. |
| 1996 | $370.9M | $670.1M | Gilead Sciences, Inc. |
| 1995 | $404.2M | $857.7M | Gilead Sciences, Inc. |
| 1994 | $400.0M | $254.6M | Amphenol Corporation |